Urinary incontinence, which is also known as the loss of bladder control is a common problem in which a person leaks urine by chance. Although, it may happen to anyone but older people especially women are severely affected by this problem. Urinary incontinence is not just a health problem, it can affect emotional, psychological and social life. Many people who have urinary incontinence are anxious to do normal daily events. They do not want to be too distant from a toilet. Urinary incontinence can keep people from enjoying life.
DelveInsight's "Urinary Incontinence Market Insights, Epidemiology, and Market Forecast 2030" report delivers an in-depth understanding of the Urinary Incontinence, historical and forecasted epidemiology as well as the Urinary Incontinence market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Urinary Incontinence market report also covers emerging drugs, current treatment practices, Urinary Incontinence market share of the individual therapies, current and forecasted Urinary Incontinence Market Size from 2017 to 2030 segmented by seven major markets. The report provides a detailed current Urinary Incontinence treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Urinary Incontinence Market Key Facts
-
As per the study by Markland et al., the standardized age prevalence of urinary incontinence was observed as 51% in women and 13.9% in men in the United States. Also, Stress Urinary Incontinence (SUI) was the most common subtype, i.e., 24.8% in women than in men while the UUI (urgency UI) was most common in men, i.e., 8.3% in the United States.
-
According to the research study of Pederson et al., the prevalence rate of urinary incontinence was observed as 48.3%. Also, it had been observed that Stress urinary incontinence dominated among younger women, and urgency urinary incontinence and mixed urinary incontinence among women with more than 80 years of age in Germany.
Urinary Incontinence Market Forecast and Market Analysis
The Urinary Incontinence market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Urinary Incontinence market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Urinary Incontinence market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Urinary Incontinence Epidemiology Forecast
The Urinary Incontinence epidemiology section covers insights about historical and current Urinary Incontinence patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Urinary Incontinence Pipeline Insights and Key Market Players
The Urinary Incontinence Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Urinary Incontinence market or expected to get launched in the market during the study period. The analysis covers Urinary Incontinence market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The Key Pharmaceutical Companies in the Urinary Incontinence market include:
Velicept Therapeutics
Urovant Sciences
IXALTIS
Cook MyoSite
Taiho Pharmaceutical
ALZA Corporation
Pfizer
Astellas Pharma
and many others
For more detailed information on Urinary Incontinence Market, visit:
https://www.delveinsight.com/report-store/urinary-incontinence-market